Last month, the German government passed a controversial cost-saving law that saw tens of thousands of patients denied access medical cannabis to flower reimbursed through statutory health insurance (GKV).
Ananda Pharma, now the leading force in pharmaceutical cannabis research in the UK, has announced that the former Chief Operating Officer of GW Pharmaceuticals and Jazz Pharmaceuticals will join its team.
In the intricate landscape of medical cannabis, Belgium has established a regulated framework to govern the use of cannabis for medicinal purposes.
Jazz Pharmaceuticals Jazz Pharmaceuticals, which has become the world’s largest exporter of medical cannabis products since it bought GW Pharmaceuticals for $7.2bn last year, raised its revenue guidance for the full year this week in its Q3 financial results.
NEW UK government data suggest that the number of NHS prescriptions for ‘licenced’ cannabis-based medicines could rise significantly this year.
